New study watches for hidden malnutrition in cancer radiation patients
NCT ID NCT07068711
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 57 head and neck cancer patients during radiotherapy to monitor their nutritional health. Researchers regularly check body composition, muscle strength, food intake, and quality of life using simple tests and questionnaires. The goal is to spot early signs of malnutrition so doctors can step in quickly and help patients feel better during treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
About 57 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jul 2025
- Expected to finish
-
Sep 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
Head and neck cancer patients from a University Hospital in Istanbul / Türkiye
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18 years and older * Diagnosed with head and neck cancer * Receiving radiotherapy at Marmara University Pendik Training and Research Hospital, Radiation Oncology Clinic * Willing to participate and able to provide written informed consent * Able to communicate and cooperate during assessments Exclusion Criteria: * Patients for whom BIA measurement is not possible (e.g., caffeine intake within the last 4 hours, alcohol use in the last 24 hours, intense physical activity in the last 24-48 hours, menstruation, presence of pacemaker or metal implants) * Patients with communication barriers or cognitive impairments * Amputees or individuals with severe upper extremity deformities * Patients with neuromuscular disorders, hemiplegia, rheumatoid arthritis, or moderate/severe neurological or cognitive impairment * Patients receiving parenteral nutrition
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Head and neck cancer are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Marmara University Pendik Training and Research Hospital Radiation Oncology Clinic
RECRUITINGIstanbul, Pendik, 34899, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Experimental pill HG146 put to the test against rare head and neck cancer
- Can a dental assistant keep cancer Patients' mouths healthier during radiation?
- Why do Non-Smokers get head and neck cancer? scientists probe tumor DNA
- Re-irradiation plus cetuximab targets head and neck tumors that return
- Sharper tumor maps: PET scans could tighten radiation beams
- Radiation plus targeted antibody tested in older head and neck cancer patients